Radioembolization for Metastatic Neuroendocrine Tumors

Radioembolization for Primary and Metastatic Tumors of the Liver

Hepatic surgery for metastatic gastrointestinal neuroendocrine tumors.

Gastrointestinal neuroendocrine cancers are of significant interest to clinicians and basic scientists. Although accuracy of diagnosis has improved with advances in radioimmune and hormonal assays and in the diagnosis of earlier disease by computed tomography (CT) and magnetic resonance imaging (MRI), many patients still present with hepatic metastases. In contrast to most metastatic gastrointe...

Radioembolization in the treatment of neuroendocrine tumors of the pancreas.

Pancreatic neuroendocrine tumors (pNET) are a rare malignancy. Many patients will present with metastatic disease most commonly to the liver. Currently the standard of care for treatment of liver metastases from neuroendocrine tumors (NETs) is surgical resection. However, only few patients are candidates for surgical resection and require alternative options. Given the rarity of this disease; d...

Transarterial Treatment of Liver Metastatic Neuroendocrine Tumors

N euroendocrine tumors (NETs) arise from neural and endocrine organs throughout the body, most commonly the gastrointestinal system and pancreas. The World Health Organization classifies welldifferentiated gastroenteropancreatic NETs into low grade and intermediate grade, and most poorly differentiated tumors are considered high grade, based on mitotic count/ Ki-67 proliferative index.1 Indolen...

Metastatic neuroendocrine hepatic tumors: resection improves survival.

BACKGROUND The optimal treatment for hepatic metastases from neuroendocrine tumors remains controversial because of the often indolent nature of these tumors. We sought to determine the effect of 3 major treatment modalities including medical therapy, hepatic artery embolization, and surgical resection, ablation, or both in patients with liver-only neuroendocrine metastases, with the hypothesis...